[Hepatocellular carcinoma and cholangiocarcinoma]

Chirurg. 2010 Oct;81(10):941-52; quiz 953. doi: 10.1007/s00104-009-1864-z.
[Article in German]

Abstract

Hepatocellular carcinoma and cholangiocarcinoma are relatively rare tumors of the gastrointestinal tract in western Europe but their incidence has been increased in recent years. Newly diagnosed intrahepatic lesions or intrahepatic cholestasis require extensive laboratory tests and imaging studies in order to confirm the diagnosis of hepatocellular carcinoma, intrahepatic or extrahepatic cholangiocarcinoma. The treatment options range from liver resection or liver transplantation to conservative measures (in cases of non-resectable lesions). This review article aims to provide an overview on the diagnostic options and the subsequent treatment.

MeSH terms

  • Bile Duct Neoplasms / epidemiology*
  • Bile Duct Neoplasms / pathology
  • Bile Duct Neoplasms / radiotherapy
  • Bile Duct Neoplasms / surgery
  • Bile Ducts, Intrahepatic / diagnostic imaging
  • Bile Ducts, Intrahepatic / pathology
  • Bile Ducts, Intrahepatic / surgery
  • Biopsy / methods
  • Carcinoma, Hepatocellular / epidemiology*
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / surgery
  • Cholangiocarcinoma / epidemiology*
  • Cholangiocarcinoma / pathology
  • Cholangiocarcinoma / radiotherapy
  • Cholangiocarcinoma / surgery
  • Cholangiopancreatography, Endoscopic Retrograde / methods
  • Combined Modality Therapy
  • Contrast Media
  • Fluorodeoxyglucose F18
  • Hepatectomy / methods
  • Humans
  • Liver Neoplasms / epidemiology*
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery
  • Liver Transplantation / methods
  • Magnetic Resonance Imaging
  • Positron-Emission Tomography / methods
  • Tomography, X-Ray Computed / methods

Substances

  • Contrast Media
  • Fluorodeoxyglucose F18